7 unchanged sentences
Performance Graph
−Removed: We were a smaller reporting company, as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, as of December 31, 2023, and are not required to provide a performance graph.
+Added: The following stock performance graph and related information shall not be deemed “soliciting material” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that we specifically incorporate it by reference into such filing.
+Added: The following performance graph compares total stockholder returns for our common stock from December 31, 2019 through December 31, 2024 against the NASDAQ Composite Index and NASDAQ Biotechnology Index, each of which we believe is a comparable index consisting of companies with similar industry classifications, and which we plan to use in our future performance graphs.
+Added: Each of the two comparative measures of cumulative total return assumes reinvestment of dividends.
+Added: The stock performance shown in the graph below is not necessarily indicative of future price performance.
+Added: Comparison of 5 Year Cumulative Total Return
+Added: Among Viking Therapeutics, Inc., the NASDAQ Composite and the NASDAQ Biotechnology Index
Unregistered Sales of Equity Securities
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.